St. Jude buys Savacor
This article was originally published in The Gray Sheet
Executive Summary
$50 mil. purchase gives the cardiac giant HeartPOD, an implantable sensor designed todetect early symptoms of congestive heart failure and provide physicians with data to customize medication dosage. Savacor is pushing the device through clinical trials in the U.S. and internationally. The sensor is implanted in a patient's left atrial chamber where it monitors atrial pressure, body temperature and cardiac electrogram. St. Jude expects the transaction to close before January...